Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025

Core Viewpoint - Inspire Medical Systems, Inc. will release its financial results for Q1 2025 on May 5, 2025, after market close, followed by a conference call to discuss the results and business developments [1]. Financial Results Announcement - The financial results for the first quarter of 2025 will be announced after the close of trading on May 5, 2025 [1]. - A conference call will take place at 5:00 p.m. Eastern Time to discuss these results [1]. Conference Call Details - A webcast of the conference call will be available on the Investor Relations page of Inspire's website [2]. - Participants wishing to ask questions must register through a provided link to receive dial-in details and a unique access code [3]. - It is recommended to register at least 10 minutes before the call starts to ensure connection [3]. - A replay of the call will be available approximately two hours after the event and archived for two weeks [4]. Company Overview - Inspire Medical Systems focuses on developing and commercializing innovative, minimally invasive solutions for obstructive sleep apnea [5]. - The company's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea [5].